Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications.

Authors:
Rossi CM; Lenti MV; Merli S; Licari A; Votto M and 2 more

Journal:
Clin Transl Allergy

Publication Year: 2022

DOI:
10.1002/clt2.12146

PMCID:
PMC9125508

PMID:
35620572

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Transl Allergy

Abbreviation: Clin Transl Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases.
Losol P; Wolska M; Wypych TP and 3 more (2024) - Transparency Score: 3/6
Bacteria and viruses and clinical outcomes of asthma-bronchiectasis overlap syndrome: A cohort stud…
Zhang XX; He JH; Pan CX and 8 more (2024) - Transparency Score: 3/6
Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of ch…
Zhai Z; Shao L; Lu Z and 8 more (2024) - Transparency Score: 3/6
Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes.
Mostmans Y; Maurer M; Richert B and 6 more (2024) - Transparency Score: 4/6
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.
Oguma T; Ishiguro T; Kamei K and 33 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST None to disclose for all authors."

Evidence found in paper:

"We thank University of Pavia (PRIN2017) for supporting our research projects."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025